I know nothing about TA but I definitely respect those that do and think it has merit. But, for me I own race shares simply because I seriously believe in the fundamentals.
I know this will sound simple minded but I’m invested here because I think that it’s ‘inevitable’ that big pharma will notice race eventually and make an offer. As a result I am not trading, not trying to time anything and probably just waiting until a buyout. A simple strategy.
Obviously a buyout is not inevitable, but that raises the question/ topic I am trying to bring up.
How much will the success of race depend on
a) the drug
b) the team/ external factors?
I’m invested relatively heavily in race because I believe bisantrene is an absolute winner. Although I think the current team are decent, it’s all been a bit turbulent and things keep taking longer than we would like. But I’ve held on because the drug seems outstanding.
So my question is- if you have an awesome drug, can you expect a large buyout with an average team? Or are there lots of incredible drugs being discovered that fail to make it to market for various reasons?
Patents, clinical trials, none of this stuff is easy. Especially for a small Aussie biotech. But then I’m only holding because bisantrene seems awesome, and I hope the team is capable of dealing with the opportunity. And my simple brain says keep it simple and just buy and hold.
This may not be the right thread for this question. But it is basically me asking: how much can awesome fundamentals override everything else long term (including TA). Obviously the answer lies somewhere in between but this might be the biggest question I ponder about race… so thoughts are welcome.
Add to My Watchlist
What is My Watchlist?
